Skip to main content
EJNMMI Reports
Fig. 2 | European Journal of Hybrid Imaging

Fig. 2

From: Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation

Fig. 2

Kaplan-Meier overall survival curves of the training dataset of 110 patients with TNM Stage 3B NSCLC, stratified by the median MTVwb of 85.6 mL. The dashed line indicates patient group with MTVwb greater than or equal to 85.6 ml with median OS of 9.5 months. The solid line indicates patient group with MTVwb less than 85.6 ml with median OS of 17.3 months. The difference is statistically significant with p = 0.02

Back to article page